ETEST® Daptomycin (DPC)Recalls & reported problems
Biomerieux SA · Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination. · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 03573026550547), received between Oct 25, 2023 and Nov 2, 2023 — classified as 6 malfunctions.
The most frequently reported specific device problem is “High Test Results” (6 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results6
Patient problems
- No Clinical Signs, Symptoms or Conditions6
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 2, 2023High Test Results; High Test Results
PRODUCT DESCRIPTION: ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN ¿G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. COMPLAINT DESCRIPTION: A CUSTOMER IN THE UNITED STATES COMPLAINED AFTER HAVING OBTAINED INCORRECT ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS WHEN TESTING FIVE PATIENTS' SAMPLES' USING ETEST TECHNIQUE. THE CUSTOMER SAID THAT THEY HAD TESTED VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATED FROM 5 DIFFERENT PATIENTS' SAMPLES' USING ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4) (LOT#1010146860 - EXPIRATION DATE : 19/07/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES AND THAT THEY HAD OBTAINED DAPTOMYCIN RESISTANT RESULTS. THE CUSTOMER REPORTED THAT THEY HAD NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING MUELLER HINTON SMALL PLATES COMPARED WITH MUELLER HINTON LARGE PLATES. LOT INFORMATION WERE NOT PROVIDED BY THE CUSTOMER. THE CU
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18055344 ↗MalfunctionNov 2, 2023High Test Results; High Test Results
PRODUCT DESCRIPTION: ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. COMPLAINT DESCRIPTION: A CUSTOMER IN THE UNITED STATES COMPLAINED AFTER HAVING OBTAINED INCORRECT ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS WHEN TESTING FIVE PATIENTS' SAMPLES' USING ETEST TECHNIQUE. THE CUSTOMER SAID THAT THEY HAD TESTED VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATED FROM 5 DIFFERENT PATIENTS' SAMPLES' USING ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4)(LOT#1010146860 - EXPIRATION DATE : 19/07/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES AND THAT THEY HAD OBTAINED DAPTOMYCIN RESISTANT RESULTS. THE CUSTOMER REPORTED THAT THEY HAD NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING MUELLER HINTON SMALL PLATES COMPARED WITH MUELLER HINTON LARGE PLATES. LOT INFORMATION WERE NOT PROVIDED BY THE CUSTOMER. THE CUST
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18055285 ↗MalfunctionNov 2, 2023High Test Results; High Test Results
PRODUCT DESCRIPTION: ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. COMPLAINT DESCRIPTION: A CUSTOMER IN THE UNITED STATES COMPLAINED AFTER HAVING OBTAINED INCORRECT ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS WHEN TESTING FIVE PATIENTS' SAMPLES' USING ETEST TECHNIQUE. THE CUSTOMER SAID THAT THEY HAD TESTED VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATED FROM 5 DIFFERENT PATIENTS' SAMPLES' USING ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4) (LOT#1010146860 - EXPIRATION DATE : 19/07/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES AND THAT THEY HAD OBTAINED DAPTOMYCIN RESISTANT RESULTS. THE CUSTOMER REPORTED THAT THEY HAD NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING MUELLER HINTON SMALL PLATES COMPARED WITH MUELLER HINTON LARGE PLATES. LOT INFORMATION WERE NOT PROVIDED BY THE CUSTOMER. THE CUS
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18055284 ↗MalfunctionNov 2, 2023High Test Results; High Test Results
PRODUCT DESCRIPTION: ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN ¿G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. COMPLAINT DESCRIPTION: A CUSTOMER IN THE UNITED STATES COMPLAINED AFTER HAVING OBTAINED INCORRECT ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS WHEN TESTING FIVE PATIENTS' SAMPLES' USING ETEST TECHNIQUE. THE CUSTOMER SAID THAT THEY HAD TESTED VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATED FROM 5 DIFFERENT PATIENTS' SAMPLES' USING ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4). (LOT#1010146860 - EXPIRATION DATE : 19/07/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES AND THAT THEY HAD OBTAINED DAPTOMYCIN RESISTANT RESULTS. THE CUSTOMER REPORTED THAT THEY HAD NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING MUELLER HINTON SMALL PLATES COMPARED WITH MUELLER HINTON LARGE PLATES. LOT INFORMATION WERE NOT PROVIDED BY THE CUSTOMER. THE C
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18055280 ↗MalfunctionNov 2, 2023High Test Results; High Test Results
PRODUCT DESCRIPTION: ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. COMPLAINT DESCRIPTION: A CUSTOMER IN THE UNITED STATES COMPLAINED AFTER HAVING OBTAINED INCORRECT ANTIBIOTIC SUSCEPTIBILITY TEST RESULTS WHEN TESTING FIVE PATIENTS' SAMPLES' USING ETEST TECHNIQUE. THE CUSTOMER SAID THAT THEY HAD TESTED VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATED FROM 5 DIFFERENT PATIENTS' SAMPLES' USING ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4) (LOT#1010146860 - EXPIRATION DATE : 19/07/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES AND THAT THEY HAD OBTAINED DAPTOMYCIN RESISTANT RESULTS. THE CUSTOMER REPORTED THAT THEY HAD NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING MUELLER HINTON SMALL PLATES COMPARED WITH MUELLER HINTON LARGE PLATES. LOT INFORMATION WERE NOT PROVIDED BY THE CUSTOMER. THE CUS
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18055263 ↗MalfunctionOct 25, 2023High Test Results; High Test Results
INTENDED USE. ETEST® IS A MANUAL, QUANTITATIVE TECHNIQUE FOR THE DETERMINATION OF ANTIMICROBIAL SUSCEPTIBILITY OF NON-FASTIDIOUS GRAM-NEGATIVE AND GRAM-POSITIVE AEROBIC BACTERIA AND FASTIDIOUS BACTERIA. THE SYSTEM COMPRISES A PREDEFINED ANTIBIOTIC GRADIENT WHICH IS USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN G/ML) OF DIFFERENT ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS TESTED ON AGAR MEDIA AFTER OVERNIGHT INCUBATION. DESCRIPTION OF THE ISSUE. A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX OF OBTAINING FALSE RESISTANT DAPTOMYCIN WITH VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) ISOLATES WHEN TESTING THREE PATIENT ISOLATES WITH THE ETEST DAPTOMYCIN DPC 256 US S30 - REFERENCE (B)(4). (LOT#1009977190 - EXPIRATION DATE : 12/04/2025) IN ASSOCIATION WITH MUELLER HINTON PLATES. INDEED, THE CUSTOMER INDICATES HAVING OBTAINED THREE VRE ISOLATES TESTED AS DAPTOMYCIN RESISTANT. THEY ALSO NOTICED INCONSISTENT RESULTS WITH DAPTOMYCIN ETEST WHEN USING SMALL VS LARGE MUELLER HINTON PLATES. CONSIDERING THAT RESISTANT DAPTOMYCIN IS A RARE OCCURRENCE, THE STRAINS WERE SENT TO AN EXTERNAL LABORATORY (ARUP) FOR TESTING. THE BROTH MICRODILUTION RESULTS FROM ARUP WERE SUSCEPTIBLE. THE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18002493 ↗
Other Manual Antimicrobial Susceptibility Test Systems devices
- ETEST® Imipenem/Relebactam (IPR)Biomerieux SA · Manual antimicrobial susceptibility test systems1 recall4 reports
- ETEST® Amikacin (AK)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall2 reports
- ETEST® Tobramycin (TM)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall1 report
- ETEST® Erythromycin (EM)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Rifampicin (RI)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Eravacycline (ERV)Biomerieux SA · Manual antimicrobial susceptibility test systems1 recall0 reports
- ETEST® Benzylpenicillin (PG)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
- ETEST® Ampicillin (AM)Biomerieux SA · Manual Antimicrobial Susceptibility Test Systems1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page